Featured Research

from universities, journals, and other organizations

Potential new treatment identified for leishmaniasis

Date:
February 2, 2012
Source:
University of Dundee
Summary:
Researchers have identified fexinidazole as a possible, much-needed, new treatment for the parasitic disease visceral leishmaniasis.

Researchers at the College of Life Sciences have identified fexinidazole as a possible, much-needed, new treatment for the parasitic disease visceral leishmaniasis.

Leishmaniasis is named after William Leishman, a Glasgwegian doctor serving with the British Army in India, who first identified the parasite in the early 1900s. The disease is the second biggest killer in Africa, Asia and Latin America after malaria, and affects 500,000 people, killing about 50-60,000 patients per year. Current drug treatments for the disease are unsatisfactory for reasons such as high cost, drug resistance or the need for hospitalisation.

Fexinidazole is already in phase 1 clinical trials for a related disease -- African sleeping sickness -- but a research team at Dundee including Dr Susan Wyllie, Professor Alan Fairlamb and colleagues has identified it as having potential in treating leishmaniasis.

Their research has been published by the journal Science Translational Medicine and was funded by the Wellcome Trust.

Tests in mice showed that the drug has a greater than 98% rate of suppressing infection of leishmaniasis, comparable to current treatments such as miltefosine and Pentostam.

These and other existing treatment options all suffer from disadvantages; they are not always safe, effective or easy to administer. The only oral drug miltefosine cannot be given to women of child-bearing age due to a substantial risk of birth defects; other drugs are costly and have to be given by injection. Thus there is a continuing need for safe and cost-effective drugs suitable for use in resource-poor settings.

Professor Fairlamb said that fexinidazole has the potential to become a safe and effective oral drug therapy for treating the severest form of visceral leishmaniasis.

"Visceral leishmaniasis is a neglected disease of poverty which causes huge problems across Africa, Asia and Latin America, killing tens of thousands of people every year," said Professor Fairlamb.

"The current treatments are far from ideal and we need to find better, cheaper and more easily delivered drugs to tackle the disease. Our research suggests that fexinidazole has strong potential to do that."

Drugs for Neglected Diseases initiative have already established that fexinidazole is safe in early clinical trials for African sleeping sickness, so it is some way along the development path.

"This has been a great team effort and I would like to acknowledge the dedication and enthusiasm of the biologists, chemists and pharmacologists involved in this discovery."

Professor Fairlamb and colleagues are based in the College of Life Sciences at Dundee, which houses the Drug Discovery Unit, formed in 2005 specifically to fill the void of research and development of drug targets for diseases of poverty like African sleeping sickness, leishmaniasis, and Chagas' disease that afflict the developing world.

Professor Fairlamb cited the inspiration of the University's former Chancellor, the Nobel prize-winning pharmacologist Sir James Black, in carrying out the research on fexinidazole.

"Sir James always liked to remind me that `the most fruitful basis for the discovery of a new drug is to start with an old drug'. This adage is particularly apt in the search for effective drugs to treat neglected tropical diseases such as visceral leishmaniasis," said Professor Fairlamb.

"Indeed, two of the existing anti-leishmanial drugs, miltefosine and amphotericin B, are examples of medicines originally developed for other purposes -- anti-cancer and anti-fungal, respectively.

"Our hope is that fexinidazole can follow them and provide relief from a disease that is a major blight across the world."


Story Source:

The above story is based on materials provided by University of Dundee. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. Wyllie, S. Patterson, L. Stojanovski, F. R. C. Simeons, S. Norval, R. Kime, K. D. Read, A. H. Fairlamb. The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis. Science Translational Medicine, 2012; 4 (119): 119re1 DOI: 10.1126/scitranslmed.3003326

Cite This Page:

University of Dundee. "Potential new treatment identified for leishmaniasis." ScienceDaily. ScienceDaily, 2 February 2012. <www.sciencedaily.com/releases/2012/02/120202151250.htm>.
University of Dundee. (2012, February 2). Potential new treatment identified for leishmaniasis. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2012/02/120202151250.htm
University of Dundee. "Potential new treatment identified for leishmaniasis." ScienceDaily. www.sciencedaily.com/releases/2012/02/120202151250.htm (accessed August 1, 2014).

Share This




More Plants & Animals News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Visitors Feel Part of the Pack at Wolf Preserve

Visitors Feel Part of the Pack at Wolf Preserve

AP (July 31, 2014) Seacrest Wolf Preserve on the northern Florida panhandle allows more than 10,000 visitors each year to get up close and personal with Arctic and British Columbian Wolves. (July 31) Video provided by AP
Powered by NewsLook.com
Florida Panther Rebound Upsets Ranchers

Florida Panther Rebound Upsets Ranchers

AP (July 31, 2014) With Florida's panther population rebounding, some ranchers complain the protected predators are once again killing their calves. (July 31) Video provided by AP
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Raw: Thousands Flocking to German Crop Circle

Raw: Thousands Flocking to German Crop Circle

AP (July 30, 2014) Thousands of people are trekking to a Bavarian farmer's field to check out a mysterious set of crop circles. (July 30) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins